ASCENSION MARIA DE LOS REYES-GARCIA PASTOR

Arroyo AB, de Los Reyes-García AM, Rivera-Caravaca JM, Valledor P, García-Barberá N, Roldán V, Vicente V, Martínez C, González-Conejero R. MiR-146a Regulates Neutrophil Extracellular Trap Formation That Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation. Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):892-902. doi: 10.1161/ATVBAHA.117.310597. Epub 2018 Feb 8. PubMed PMID: 29437577.

AÑO: 2018; IF: 6.618

29437577

Arroyo AB, de Los Reyes-García AM, Teruel-Montoya R, Vicente V, González-Conejero R, Martínez C. microRNAs in the haemostatic system: More than witnesses of thromboembolic diseases? Thromb Res. 2018 Jun;166:1-9. doi: 10.1016/j.thromres.2018.03.021. Epub 2018 Apr 6. Review. PubMed PMID: 29649766.

AÑO: 2018; IF: 3.266

29649766

De Los Reyes-Garcia AM, Arroyo AB, Teruel-Montoya R, Vicente V, Lozano ML, Gonzalez-Conejero R, Martinez C. MicroRNAs as potential regulators of platelet function and bleeding diatheses. Platelets. 2019;30(7):803-808. doi: 10.1080/09537104.2018.1475635. Epub 2018 May 22. PubMed PMID: 29787683.

AÑO: 2019; IF: 3.378

29787683

Lozano ML, Garabet L, Fernandez-Perez MP, De Los Reyes-Garcia AM, Diaz-Lozano P, Garcia-Barbera N, Aguila S, Vicente V, Ghanima W, Martinez C, Gonzalez-Conejero R. Platelet activation and neutrophil extracellular trap (NET) formation in immune thrombocytopenia: is there an association? Platelets. 2020 Oct 2;31(7):906-912. doi: 10.1080/09537104.2019.1696456. Epub 2019 Nov 24. PubMed PMID: 31762368.

AÑO: 2020; IF: 3.862

31762368

Ferrer-Marin F, Arroyo AB, Bellosillo B, Cuenca EJ, Zamora L, Hernandez-Rivas JM, Hernandez-Boluda JC, Fernandez-Rodriguez C, Luno E, Garcia Hernandez C, Kerguelen A, Fiallo-Suarez DV, Gomez-Casares MT, Ayala R, Velez P, Boque C, Garcia-Gutierrez V, Arrizabalaga B, Estrada N, Cifuentes R, Arcas I, de Los Reyes-Garcia AM, Besses C, Vicente V, Alvarez-Larran A, Teruel-Montoya R, Gonzalez-Conejero R, Martinez C; GEMFIN Group. miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk. Leukemia. 2020 Oct;34(10):2648-2659. doi: 10.1038/s41375-020-0767-3. Epub 2020 Feb 27. PubMed PMID: 32107471.

AÑO: 2020; IF: 12.883

32107471